Two Sigma Investments, LP Intellia Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 614,568 shares of NTLA stock, worth $13.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
614,568
Previous 507,887
21.0%
Holding current value
$13.8 Million
Previous $15.5 Million
9.18%
% of portfolio
0.04%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding NTLA
# of Institutions
313Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$246 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$204 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$204 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$103 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$94.2 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.7B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...